BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22335959)

  • 1. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
    Nowrousian MR; Dunst J; Vaupel P
    Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarifying the use of erythropoietic agents.
    Smith RE
    J Support Oncol; 2004; 2(3):200, 202; author reply 202. PubMed ID: 15328822
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin therapy in cancer-related anaemia, yes or no?
    Herrmann R
    Intern Med J; 2008 Oct; 38(10):749-50. PubMed ID: 19143876
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer- and treatment-related anemia.
    Rodgers GM; Cella D; Chanan-Khan A; Chesney C; Cleeland C; Coccia PF; Demetri GD; Djulbegovic B; Garst JL; Gore M; Kraut EH; Lin WC; Millenson M; Mock V; Reinke D; Rosenthal J; Sabbatini P
    J Natl Compr Canc Netw; 2005 Nov; 3(6):772-89. PubMed ID: 16316613
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
    Anand A; Anand A; Anand N
    Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
    [No Abstract]   [Full Text] [Related]  

  • 7. A multidisciplinary approach for establishing standardized anemia procedures.
    Miskin D; Hoechner C
    J Support Oncol; 2005; 3(6 Suppl 4):18-9. PubMed ID: 16355553
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
    Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
    Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing quality of life as a factor in treatment choices for chemotherapy-induced anemia.
    Koopman W; Iakiri S
    J Support Oncol; 2005; 3(6 Suppl 4):20-1. PubMed ID: 16355554
    [No Abstract]   [Full Text] [Related]  

  • 10. Is anemia of cancer different from chemotherapy-induced anemia?
    Steensma DP
    J Clin Oncol; 2008 Mar; 26(7):1022-4. PubMed ID: 18227523
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin: high profile, high scrutiny.
    Crawford J
    J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron deficiency and anemia in oncology].
    Scotté F; Launay-Vacher V; Ray-Coquard I
    Bull Cancer; 2012 May; 99(5):563-70. PubMed ID: 22516641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms.
    Hadland BK; Longmore GD
    J Clin Oncol; 2009 Sep; 27(25):4217-26. PubMed ID: 19636005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythropoietin and cancer].
    Pérez Manga G
    Rev Clin Esp; 1992 Mar; 190(5):219-21. PubMed ID: 1579692
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.
    Hinds PS; Hockenberry M; Feusner J; Hord JD; Rackoff W; Rozzouk BI
    J Support Oncol; 2005; 3(6 Suppl 4):10-1. PubMed ID: 16355549
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
    Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing chemotherapy-induced anemia management with the use of patient flow sheets.
    Morehead L; Zobec A; Pacheco-Gach C; Glick R; Flippin SB
    J Support Oncol; 2005; 3(6 Suppl 4):14-5. PubMed ID: 16355551
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin-stimulating agents: new data yield new insights.
    Zitella L
    Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):36-8. PubMed ID: 18154208
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer- and chemotherapy-induced anemia.
    Rodgers GM; Becker PS; Bennett CL; Cella D; Chanan-Khan A; Chesney C; Cleeland C; Coccia PF; Djulbegovic B; Garst JL; Gilreath JA; Kraut EH; Lin WC; Matulonis U; Millenson M; Reinke D; Rosenthal J; Sabbatini P; Schwartz RN; Stein RS; Vij R;
    J Natl Compr Canc Netw; 2008 Jul; 6(6):536-64. PubMed ID: 18597709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.